Comunicado sobre o uso de Omalizumabe em pacientes com Urticária Crônica Espontânea e a COVID-19 / Report on the use of Omalizumab in patients with Chronic Spontaneous Urticaria and COVID-19
Arq. Asma, Alerg. Imunol
;
4(1): 136-137, jan.mar.2020. ilus
Article
in Portuguese
| LILACS
| ID: biblio-1381819
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Omalizumab
/
Chronic Urticaria
/
COVID-19
Limits:
Humans
Language:
Portuguese
Journal:
Arq. Asma, Alerg. Imunol
Journal subject:
Biologia
/
Cincia
Year:
2020
Type:
Article
Affiliation country:
Brazil
Institution/Affiliation country:
Associação Brasileira de Alergia e Imunologia/BR
/
Rede Urticária Brasil (RUBRA)/BR
Similar
MEDLINE
...
LILACS
LIS